Dr David Pruyne and Dr Jeff Amack are Associate Professors of Cell and Developmental Biology at Upstate Medical University. Dr Prunye’s lab primarily utilizes a C. elegans model system to study muscle cell growth, but recently teamed up with Dr Amack to investigate whether vertebrates show similar effects.
Pruyne and Amack wanted to disrupt the genes fhod3a and fhod3b in zebrafish, as they are associated with familial hypertrophic cardiomyopathy – a condition where heart muscle grows abnormally thick and makes it hard for the heart to pump.
But, when working with these genes it is necessary to target very specific point mutations within the exons because these genes are subject to alternative splicing which, in turn, can obscure the isoform specific effect.
Pruyne and Amack leveraged InVivo Biosystems’ Custom Validated Injection Mix offering to design and create a validated injection mix for the generation of a novel zebrafish line carrying a targeted in frame deletion to disrupt fhod3a and fhod3b.
InVivo Biosystems’ experienced team can take over and deliver the results you need through our gene editing services. We welcome the opportunity to discuss your project with you.
See the Amack & Pruyne Customer Story to learn more about Dr. Pruyne and Dr Amack’s research, why they chose to leverage the InVivo Biosystems’ Custom Validated Injection Mix offering, and the benefits of using our platform.
